Archive for 2018
P.E.I. BioAlliance executive director reflects on the sector’s growth
It’s become a familiar message on the Island – that a company doesn’t have to be in Toronto or Montreal or Vancouver to be globally successful in the biotech sector. In this article posted in The Guardian Newspaper, BioAlliance Executive Director, Rory Francis talks about the growth of the PEI Bioscience Cluster.
It can happen here
Charlottetown-based Cannabis and help oil extraction company has clients around the world and is looking to expand. Read more in this article by Terrence McEachern in The Guardian Newspaper.
Dosecann Inc. – Global Cannabis Solutions
Business View Magazine interviews Greg Boone, Founder and CEO of Dosecann Inc., for our focus on Canadian cannabis companies.
Incorporated in 2016, Dosecann Inc. is a Canadian licensed dealer dedicated to developing cannabis solutions for the global cannabis industry. Proudly located in Charlottetown, PEI, Dosecann has assembled a world-class team housed in a purpose-built, 42,000-sq.-ft. GMP-compliant facility in the BioCommons Research Park that will be the hub for cannabis extraction, product innovation and formulation, and manufacturing. Read full interview here
Women in Aquaculture: Dr. Laura Braden
Dr. Laura Braden, an eminent sea lice researcher who now works for AquaBounty, lives on Prince Edward Island, Canada, with her husband-to-be, a young baby, two German shepherds and a Norwegian forest cat. Here, she explains how genetic engineering can help save the planet. Read full story here.
Canada’s Health Department Proposes Non-competitive Regulatory and Maintenance Service Fees for Veterinary Drugs
International Animal Health Journal, February 2018
Analysis of the proposed service fees for veterinary drug review and maintenance brings the CAHI to the conclusion that should this proposal come to be implemented, as is, sales for 58% of the current livestock products will not support a new registration, while 52% of companion animal product sales will not support introduction to the Canadian market. If innovation costs of 5% of the total R&D costs are included in the calculation, 79% of the livestock products (74% for companion animal) fall below the financial threshold to support product registration and launch in Canada.
Natural products and cancer immunotherapy selected in latest CECR competition
Research Money, March 2017
A stronger focus on commercialization has helped to distinguish two new networks joining the Centres of Excellence for Commercialization and Research (CECR) program in a tough competition that saw two winners out of field of nine. Natural Products Canada (NPC) was the first CECR awarded for R&D in the field of natural products and will receive $14 million over five years to establish four nodes in a national network for commercializing natural products for human and animal health, agricultural products and industrial chemicals. Spearheaded by the PEI BioAlliance, the Charlottetown-based NPC is the first CECR to be headquartered in the Maritimes. A recent article from Research Money looks at success factors and sustainability.